Touchlight and 20Med partner on vaccine platform
Link-up has already delivered data showing the promise of nanoparticle-formulated doggybone DNA
Read More
Tag: Touchlight
Odimma Therapeutics and Touchlight announce clinical material collaboration
Partnership aims to progress personalised cancer therapy by incorporating doggybone DNA
Read More
Touchlight receives funding to develeop DNA vaccine platform
Bill & Melinda Gates Foundation grant will boost potential of nanoparticle-formulated doggybone DNA
Read More
Touchlight signs patent agreement with Pfizer
Deal involves the manufacturing of mRNA-based vaccines, therapeutics and gene therapies
Read More
DNA production specialist Touchlight raises £42m
Proceeds will be used to ‘more than triple’ UK biotech’s manufacturing capabilities
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
